First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure - Université Clermont Auvergne Accéder directement au contenu
Article Dans Une Revue Antiviral Research Année : 2022

First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure

Dates et versions

hal-03851053 , version 1 (14-11-2022)

Identifiants

Citer

Clotilde Muller, Valentin Tilloy, Emilie Frobert, Linda Feghoul, Isabelle Garrigue, et al.. First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure. Antiviral Research, 2022, 204, pp.105361. ⟨10.1016/j.antiviral.2022.105361⟩. ⟨hal-03851053⟩
84 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More